Normal ageing in adults with Down's syndrome: a longitudinal study
Abstract
The ubiquitous presence of the neuropathology of Alzheimer disease (AD) in individuals with Down's syndrome (DS) over 40 years of age suggests that this group of people will exhibit a high prevalence of dementia of the Alzheimer type (DAT) as they age. The present study indicates that there is a clear discrepancy between the presumed presence of AD neuropathology and the clinical expression of DAT among older people with DS. In the first 6 years of a longitudinal study, the present authors compared 91 adults (31-63 years of age) with DS and mild or moderate mental retardation to 64 adults (31-76 years of age) with other forms of mental retardation (MR) on yearly measures of mental status, short- and long-term memory, speeded psychomotor function, and visuospatial organization. The results indicated that, over repeated testing on the verbal long-term memory test, younger participants with DS showed small increases in their scores, while older participants with DS showed very slight decreases. Overall performance scores on this test and a speeded psychomotor task were poorer for both diagnostic groups in individuals aged 50 years and older. The magnitude and type of these selective changes in performance were consistent with performance profiles observed in older healthy adults without mental retardation on tests measuring similar cognitive functions. Only four out of the 91 people with DS in the present sample showed changes in functioning that have led to a diagnosis of possi…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Virtually all people with full trisomy 21 are expected to develop the pathophysiological changes of Alzheimer's disease by their early to mid-40s.
“Because virtually all people with full trisomy 21 are expected to develop the pathophysiological changes of AD by their earyl to mid‐40's, this longitudinal design provides a unique opportunity to track physiological and cognitive changes through the clinically asymptomatic preclinical to the clinical stages of dementia.”
From The Alzheimer's Biomarker Consortium–Down Syndrome (ABC‐DS): A 10‐year report (2025) · cites this paper as [5]
Most adults with Down syndrome will have the neuropathologies characteristic of Alzheimer's disease by their early to mid-40s.
“In fact, most adults with DS will have the neuropathologies characteristic of AD by the time they reach their early to mid‐40s that anticipates further progression some years or decades later. 3 , 4 , 5 , 6”
From The Alzheimer's Biomarker Consortium–Down Syndrome (ABC‐DS): A 10‐year report (2025) · cites this paper as [5]
Cited by
Sorted by citations
Dementia in Down syndrome: unique insights for Alzheimer disease research
Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383 · see citing works
Fortea, J., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., Barroeta, I., Fernández, S., Altuna, M., Pegueroles, J., Montal, V., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30689-9 · Cited by 340 · see citing works
Communication breaks-Down: From neurodevelopment defects to cognitive disabilities in Down syndrome
Contestabile, A., Benfenati, F., & Gasparini, L. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.003 · Cited by 134 · see citing works
The Alzheimer's Biomarker Consortium–Down Syndrome (ABC‐DS): A 10‐year report
Handen, B. L., Mapstone, M., Hartley, S., Andrews, H., Christian, B., Lee, J. H., Tudorascu, D., Hom, C., Ances, B. M., Zaman, S., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70294 · Cited by 29 · see citing works
Self-citation
- Authors
- Devenny, D. A., Silverman, W. P., Hill, A. L., Jenkins, E., Sersen, E. A., & Wisniewski, K. E.
- Venue
- Journal of Intellectual Disability Research
- Publisher
- Wiley
- Published
- 1996-06
- Volume
- 40
- Issue
- 3
- Pages
- 208-221
- ISSN
- 0964-2633 (ISSN-L)
- 1365-2788
- OpenAlex
- W2043270657
- Cited by
- 171
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 5 · 2013: 6 · 2012: 5
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Intellectual Disability Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01ag011531-10, 5p01hd022634-05)
- National Institute on Aging (P01-AG1 1531)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01 HD22634)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Williams Syndrome Research
- Keywords
- Down syndrome, normal aging, Alzheimer's disease, dementia risk, intellectual disability, long-term memory, psychomotor speed, age-related cognitive decline, thyroid dysfunction
- MeSH terms
- Adult, Age Factors, Aged, Alzheimer Disease, Down Syndrome, Humans, Intelligence, Longitudinal Studies, Mental Status Schedule, Middle Aged, Neuropsychological Tests, Mental Recall, Reference Values, Risk, Wechsler Scales
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review